Management of pulmonary recurrence of hepatocellular carcinoma after receiving a living-donor liver transplantation--a case report

Tadafumi Asaoka, Shigeru Marubashi, Keizo Dono, Naoki Hama, Chiwan Kim, Shogo Kobayashi, Yutaka Takeda, Hiroaki Nagano, Koji Umeshita, Morito Monden, Yuichiro Doki, Masaki Mori

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

We report on the treatment experience of five living-donor liver transplantation (LDLT) recipients for hepatocellular carcinoma (HCC) with pulmonary metastases. Between March 1998 and December 2007, five patients who underwent LDLT for HCC were identified with a routine follow-up of pulmonary metastases: Two patients underwent a radical resection for pulmonary recurrence of HCC, Two patients were only observed by palliative treatment, and one patient had chemotherapy using S-1/IFN. The survival range from pulmonary recurrence of HCC was 7.5 to 43.0 months and the median survival time was 18.9 months. Only one of the 5 patients who underwent a surgical resection of pulmonary recurrence is still alive without a new recurrence for a long period of time.

Original languageEnglish
Pages (from-to)2086-2087
Number of pages2
JournalGan to kagaku ryoho. Cancer & chemotherapy
Volume35
Issue number12
Publication statusPublished - Jan 1 2008
Externally publishedYes

Fingerprint

Living Donors
Liver Transplantation
Hepatocellular Carcinoma
Recurrence
Lung
Neoplasm Metastasis
Survival
Palliative Care
Drug Therapy

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Cite this

Management of pulmonary recurrence of hepatocellular carcinoma after receiving a living-donor liver transplantation--a case report. / Asaoka, Tadafumi; Marubashi, Shigeru; Dono, Keizo; Hama, Naoki; Kim, Chiwan; Kobayashi, Shogo; Takeda, Yutaka; Nagano, Hiroaki; Umeshita, Koji; Monden, Morito; Doki, Yuichiro; Mori, Masaki.

In: Gan to kagaku ryoho. Cancer & chemotherapy, Vol. 35, No. 12, 01.01.2008, p. 2086-2087.

Research output: Contribution to journalArticle

Asaoka, T, Marubashi, S, Dono, K, Hama, N, Kim, C, Kobayashi, S, Takeda, Y, Nagano, H, Umeshita, K, Monden, M, Doki, Y & Mori, M 2008, 'Management of pulmonary recurrence of hepatocellular carcinoma after receiving a living-donor liver transplantation--a case report', Gan to kagaku ryoho. Cancer & chemotherapy, vol. 35, no. 12, pp. 2086-2087.
Asaoka, Tadafumi ; Marubashi, Shigeru ; Dono, Keizo ; Hama, Naoki ; Kim, Chiwan ; Kobayashi, Shogo ; Takeda, Yutaka ; Nagano, Hiroaki ; Umeshita, Koji ; Monden, Morito ; Doki, Yuichiro ; Mori, Masaki. / Management of pulmonary recurrence of hepatocellular carcinoma after receiving a living-donor liver transplantation--a case report. In: Gan to kagaku ryoho. Cancer & chemotherapy. 2008 ; Vol. 35, No. 12. pp. 2086-2087.
@article{4a9ce76f49df42eab749381d2ccb82e6,
title = "Management of pulmonary recurrence of hepatocellular carcinoma after receiving a living-donor liver transplantation--a case report",
abstract = "We report on the treatment experience of five living-donor liver transplantation (LDLT) recipients for hepatocellular carcinoma (HCC) with pulmonary metastases. Between March 1998 and December 2007, five patients who underwent LDLT for HCC were identified with a routine follow-up of pulmonary metastases: Two patients underwent a radical resection for pulmonary recurrence of HCC, Two patients were only observed by palliative treatment, and one patient had chemotherapy using S-1/IFN. The survival range from pulmonary recurrence of HCC was 7.5 to 43.0 months and the median survival time was 18.9 months. Only one of the 5 patients who underwent a surgical resection of pulmonary recurrence is still alive without a new recurrence for a long period of time.",
author = "Tadafumi Asaoka and Shigeru Marubashi and Keizo Dono and Naoki Hama and Chiwan Kim and Shogo Kobayashi and Yutaka Takeda and Hiroaki Nagano and Koji Umeshita and Morito Monden and Yuichiro Doki and Masaki Mori",
year = "2008",
month = "1",
day = "1",
language = "English",
volume = "35",
pages = "2086--2087",
journal = "Japanese Journal of Cancer and Chemotherapy",
issn = "0385-0684",
publisher = "Japanese Journal of Cancer and Chemotherapy Publishers Inc.",
number = "12",

}

TY - JOUR

T1 - Management of pulmonary recurrence of hepatocellular carcinoma after receiving a living-donor liver transplantation--a case report

AU - Asaoka, Tadafumi

AU - Marubashi, Shigeru

AU - Dono, Keizo

AU - Hama, Naoki

AU - Kim, Chiwan

AU - Kobayashi, Shogo

AU - Takeda, Yutaka

AU - Nagano, Hiroaki

AU - Umeshita, Koji

AU - Monden, Morito

AU - Doki, Yuichiro

AU - Mori, Masaki

PY - 2008/1/1

Y1 - 2008/1/1

N2 - We report on the treatment experience of five living-donor liver transplantation (LDLT) recipients for hepatocellular carcinoma (HCC) with pulmonary metastases. Between March 1998 and December 2007, five patients who underwent LDLT for HCC were identified with a routine follow-up of pulmonary metastases: Two patients underwent a radical resection for pulmonary recurrence of HCC, Two patients were only observed by palliative treatment, and one patient had chemotherapy using S-1/IFN. The survival range from pulmonary recurrence of HCC was 7.5 to 43.0 months and the median survival time was 18.9 months. Only one of the 5 patients who underwent a surgical resection of pulmonary recurrence is still alive without a new recurrence for a long period of time.

AB - We report on the treatment experience of five living-donor liver transplantation (LDLT) recipients for hepatocellular carcinoma (HCC) with pulmonary metastases. Between March 1998 and December 2007, five patients who underwent LDLT for HCC were identified with a routine follow-up of pulmonary metastases: Two patients underwent a radical resection for pulmonary recurrence of HCC, Two patients were only observed by palliative treatment, and one patient had chemotherapy using S-1/IFN. The survival range from pulmonary recurrence of HCC was 7.5 to 43.0 months and the median survival time was 18.9 months. Only one of the 5 patients who underwent a surgical resection of pulmonary recurrence is still alive without a new recurrence for a long period of time.

UR - http://www.scopus.com/inward/record.url?scp=58749113473&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=58749113473&partnerID=8YFLogxK

M3 - Article

C2 - 19106532

AN - SCOPUS:58749113473

VL - 35

SP - 2086

EP - 2087

JO - Japanese Journal of Cancer and Chemotherapy

JF - Japanese Journal of Cancer and Chemotherapy

SN - 0385-0684

IS - 12

ER -